Safar; Pavel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Safar; Pavel.The latest application filed is for "test button for an electrical switching device and electrical switching device".

Company Profile

0.13.11

Safar; Pavel - Pisecna CZ
Safar; Pavel - Oro Valley AZ
Safar; Pavel - Tucson AZ
Safar; Pavel - Tuscon AZ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Test button for an electrical switching device and electrical switching device Grant 8,860,535 - Augusta , et al. October 14, 2	2014-10-14
Pyridylvinylpyrazoloquinolines as PAR1 inhibitors Grant 8,791,133 - Schoenafinager , et al. July 29, 2	2014-07-29
Test Button For An Electrical Switching Device And Electrical Switching Device App 20130199902 - AUGUSTA; Zbynek ; et al.	2013-08-08
Pyridylvinylpyrazoloquinolines as PAR1 inhibitors App 20130040981 - SCHOENAFINAGER; Karl ; et al.	2013-02-14
Hexahydro-pyrazino[1,2-A]pyrimidine-4,7-dione derivatives substituted with amino acids Grant 7,994,168 - Lennig , et al. August 9, 2	2011-08-09
Substituted hexahydropyrazino [1,2-A] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments Grant 7,750,005 - Flohr , et al. July 6, 2	2010-07-06
Nitrogen-substituted hexahydropyrazino[1,2-A]pyrimidine-4,7-dione derivatives, processes for their preparation and their use as medicaments Grant 7,652,007 - Flohr , et al. January 26, 2	2010-01-26
Substituted Hexahydropyrazino [1,2-a] Pyrimidine-4,7-dione Derivatives, Process For Their Preparation And Their Use As Medicaments App 20080221113 - Flohr; Stefanie ; et al.	2008-09-11
Substituted sulfonamides and ureas useful for inhibiting kinase activity Grant 7,393,849 - Safar , et al. July 1, 2	2008-07-01
Substituted hexahydropyrazino [1,2-a] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments Grant 7,390,814 - Flohr , et al. June 24, 2	2008-06-24
Substituted sulfonamides and ureas useful for inhibiting kinase activity Grant 7,323,457 - Safar , et al. January 29, 2	2008-01-29
Substituted Sulfonamides And Ureas Useful For Inhibiting Kinase Activity App 20070208008 - SAFAR; Pavel ; et al.	2007-09-06
Hexahydro-pyrazino[1,2-a]pyrimidine-4,7-dione Derivatives Substituted With Amino Acids App 20070197539 - Lennig; Petra ; et al.	2007-08-23
Substituted Sulfonamides And Ureas Useful For Inhibiting Kinase Activity App 20070191347 - SAFAR; Pavel ; et al.	2007-08-16
Substituted sulfonamides and ureas useful for inhibiting kinase activity Grant 7,223,763 - Safar , et al. May 29, 2	2007-05-29
Nitrogen-substituted hexahydropyrazino[1,2-a]pyrimidine-4,7-dione derivatives, processes for their preparation and their use as medicaments App 20050085483 - Flohr, Stefanie ; et al.	2005-04-21
Substituted sulfonamides and ureas useful for inhibiting kinase activity App 20040204582 - Safar, Pavel ; et al.	2004-10-14
Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity Grant 6,777,577 - Safar , et al. August 17, 2	2004-08-17
Factor Xa inhibitors Grant 6,759,384 - Al-Obeidi , et al. July 6, 2	2004-07-06
Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity App 20030087832 - Safar, Pavel ; et al.	2003-05-08
Method of treating hyperresorptive bone disorders App 20030045480 - Safar, Pavel ; et al.	2003-03-06
Factor Xa inhibitors Grant 5,849,510 - Al-Obeidi , et al. December 15, 1	1998-12-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.